Huntsman Cancer Institute (HCI) began with the idea that it is possible to defeat cancer.

Karen and Jon M. Huntsman
Founders and Principal Benefactors

A notoriously dreadful illness, cancer is the second leading cause of death in the United States. It strikes regardless of race, socioeconomic status, gender, or age.

Our idea was ambitious and our challenge formidable, but our commitment is steadfast. We have built an institute that unites the world’s best scientists and physicians to conquer cancer.

HCI is a place where more than 150 members in our National Cancer Institute (NCI)-Designated Cancer Center are committed to advance the most compelling science. This NCI designation is recognized throughout the world as the mark of an elite group of organizations leading the charge to understand, treat, prevent and—ultimately—find a cure for cancer.

Our researchers are trailblazers. Their ideas begin with a hypothesis, informed by years of experience, about a better way to approach cancer. They are challenged to think beyond the standard of care that exists today to how their science can raise the bar for the cancer care of tomorrow.

Ideas lead to research studies or experiments. Our facilities include state-of-the-art laboratories and cutting-edge research equipment such as mass spectrometry and high-throughput DNA sequencing. The expertise of each individual is bolstered by a rich environment of creative minds who understand collaboration is a key to rapidly advancing the best ideas. Our investigators mentor a cadre of talented young students and postdoctoral fellows. These trainees play a key role in cancer research today, and will lead the fight against cancer in years to come. Generous donors stand by our side, enabling us to cultivate these big ideas in their earliest stages.

Mary Beckerle, PhD, 
Chief Executive Officer and Director

Our commitment to collaboration goes beyond our cancer campus. Through an innovative alliance with Intermountain Healthcare, HCI has improved access to the highest quality cancer research and care throughout the state of Utah. Our work with cancer clinics in neighboring states helps fortify this commitment.

Basic science breakthroughs lead to innovative clinical trials. HCI has a robust clinical trials portfolio, including a Phase I program that witnessed significant growth in 2010, offering patients treatment options that would not exist otherwise.

Not every idea travels the full spectrum from hypothesis to improved cancer treatment. But each idea illuminates our understanding of how cancer begins, how it behaves, how best to treat it, and how to prevent it outright. Each idea provides those who are impacted by cancer with a reason to hope. HCI is a place where ideas begin and hope never ends.



American Association for Cancer Research Recognizes Jon M. Huntsman, Philanthropist of the Highest Order

In honor of his significant and sustained contributions to cancer research, Jon M. Huntsman was presented with a Distinguished Public Service Award from the American Association for Cancer Research (AACR) in 2010.

Mr. Huntsman joined John Neiderhuber, MD, director of the National Cancer Institute, and Julie Fleshman, president of the Pancreatic Cancer Action Network, as fellow awardees.

"We are so grateful for the contributions of these three extraordinary individuals," said Margaret Foti, PhD, MD, chief executive officer of the AACR. "They have all given selflessly of their time and efforts to public service and cancer research."

The Distinguished Public Service Award was presented during opening ceremonies at the AACR 101st Annual Meeting held April 18, 2010, in Washington, D.C. Past recipients of this prestigious award include Lance Armstrong, Senator Arlen Specter, Senator Orrin Hatch, and Nancy Brinker, founder of the Susan G. Komen Foundation.